
Beyond Air, Inc. – NASDAQ:XAIR
Beyond Air stock price today
Beyond Air stock price monthly change
Beyond Air stock price quarterly change
Beyond Air stock price yearly change
Beyond Air key metrics
Market Cap | 30.31M |
Enterprise value | 173.27M |
P/E | -3.43 |
EV/Sales | N/A |
EV/EBITDA | -3.19 |
Price/Sales | N/A |
Price/Book | 3.84 |
PEG ratio | 0.10 |
EPS | N/A |
Revenue | N/A |
EBITDA | -43.54M |
Income | -61.61M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBeyond Air stock price history
Beyond Air stock forecast
Beyond Air financial statements
Dec 2021 | 0 | -7.73M | |
---|---|---|---|
Mar 2022 | 0 | -20.00M | |
Mar 2023 | 0 | -20.16M | |
Mar 2024 | 470K | -13.70M | -2916.38% |
Sep 2025 | 8.6M | -11.36M | -132.11% |
---|---|---|---|
Oct 2025 | 7.14M | -8.34M | -116.86% |
Dec 2025 | 8.81M | -7.73M | -87.72% |
Mar 2026 | 13.3M | -10.06M | -75.66% |
Analysts Price target
Financials & Ratios estimates
Sep 2022 | 82039000 | 18.38M | 22.41% |
---|---|---|---|
Dec 2022 | 73959000 | 18.51M | 25.04% |
Mar 2023 | 68749000 | 26.72M | 38.87% |
Mar 2024 | 56961000 | 29.77M | 52.27% |
Dec 2021 | -6.33M | -419K | 50.71M |
---|---|---|---|
Mar 2022 | -7.9M | -339K | 5.66M |
Mar 2023 | -8.44M | 8.86M | 3.40M |
Mar 2024 | -10.72M | -1.66M | 15.89M |
Beyond Air alternative data
Aug 2023 | 98 |
---|---|
Sep 2023 | 98 |
Oct 2023 | 98 |
Nov 2023 | 98 |
Dec 2023 | 98 |
Jan 2024 | 98 |
Feb 2024 | 98 |
Mar 2024 | 98 |
Apr 2024 | 98 |
May 2024 | 98 |
Jun 2024 | 98 |
Jul 2024 | 107 |
Beyond Air other data
Period | Buy | Sel |
---|---|---|
Nov 2023 | 10000 | 0 |
Dec 2023 | 1277775 | 28423 |
Sep 2024 | 5442520 | 0 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Purchase | CAREY ROBERT director | Warrants to purchase Common Stock | 1,880,565 | $0.38 | $712,734 | ||
Purchase | CAREY ROBERT director | Common Stock | 1,476,626 | $0.5 | $744,220 | ||
Purchase | CAREY ROBERT director | Pre-funded Warrants to purchase Common Stock | 480,179 | N/A | N/A | ||
Purchase | CAREY ROBERT director | Warrants to purchase Common Stock | 102,382 | $0.38 | $38,803 | ||
Purchase | CAREY ROBERT director | Pre-funded Warrants to purchase Common Stock | 26,142 | N/A | N/A | ||
Purchase | LISI STEVEN A. director, officer.. | Common Stock | 1,476,626 | $0.5 | $744,220 | ||
Sale | AVNIEL AMIR director, officer.. | Common Stock | 11,267 | $2.06 | $23,233 | ||
Sale | AVNIEL AMIR director, officer.. | Common Stock | 13,733 | $2.06 | $28,221 | ||
Sale | MYERS JEFF LYNN officer: Chief Medical Officer | Common Stock | 3,423 | $2.21 | $7,579 | ||
Purchase | LISI STEVEN A. director, officer.. | Common Stock | 77,775 | $1.63 | $126,773 |
Patent |
---|
Application Filling date: 25 Nov 2020 Issue date: 4 Aug 2022 |
Application Filling date: 2 Aug 2021 Issue date: 27 Jan 2022 |
Application Filling date: 30 Apr 2020 Issue date: 15 Oct 2020 |
Application Filling date: 30 Apr 2020 Issue date: 10 Sep 2020 |
Quarter | Transcript |
---|---|
Q4 2024 24 Jun 2024 | Q4 2024 Earnings Call Transcript |
Q3 2024 13 Feb 2024 | Q3 2024 Earnings Call Transcript |
Q2 2024 13 Nov 2023 | Q2 2024 Earnings Call Transcript |
Q1 2024 10 Aug 2023 | Q1 2024 Earnings Call Transcript |
Insider | Compensation |
---|---|
Mr. Steven Adam Lisi (1971) Chief Executive Officer & Chairman | $450,000 |
Mr. Amir Avniel (1974) Co-Founder, Pres, Chief Operating Officer & Director | $400,000 |
Mr. Douglas J. Beck CPA, CPA (1961) Consultant | $250,000 |
-
What's the price of Beyond Air stock today?
One share of Beyond Air stock can currently be purchased for approximately $2.38.
-
When is Beyond Air's next earnings date?
Unfortunately, Beyond Air's (XAIR) next earnings date is currently unknown.
-
Does Beyond Air pay dividends?
No, Beyond Air does not pay dividends.
-
How much money does Beyond Air make?
Beyond Air has a market capitalization of 30.31M.
-
What is Beyond Air's stock symbol?
Beyond Air, Inc. is traded on the NASDAQ under the ticker symbol "XAIR".
-
What is Beyond Air's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Beyond Air?
Shares of Beyond Air can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Beyond Air's key executives?
Beyond Air's management team includes the following people:
- Mr. Steven Adam Lisi Chief Executive Officer & Chairman(age: 54, pay: $450,000)
- Mr. Amir Avniel Co-Founder, Pres, Chief Operating Officer & Director(age: 51, pay: $400,000)
- Mr. Douglas J. Beck CPA, CPA Consultant(age: 64, pay: $250,000)
-
Is Beyond Air founder-led company?
Yes, Beyond Air is a company led by its founder Mr. Amir Avniel.
-
How many employees does Beyond Air have?
As Jul 2024, Beyond Air employs 107 workers, which is 9% more then previous month and 9% more then previous quarter.
-
When Beyond Air went public?
Beyond Air, Inc. is publicly traded company for more then 7 years since IPO on 12 Jun 2018.
-
What is Beyond Air's official website?
The official website for Beyond Air is beyondair.net.
-
Where are Beyond Air's headquarters?
Beyond Air is headquartered at 900 Stewart Avenue, Garden City, NY.
-
How can i contact Beyond Air?
Beyond Air's mailing address is 900 Stewart Avenue, Garden City, NY and company can be reached via phone at +51 66 658200.
Beyond Air company profile:

Beyond Air, Inc.
beyondair.netNASDAQ
107
Medical - Devices
Healthcare
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
Garden City, NY 11530
CIK: 0001641631
ISIN: US08862L1035
CUSIP: 08862L103